Rosario García Campelo

Statistics

Publications

Citations

H-Index

Active since

2008

Affiliations

Complexo Hospitalario Universitario A Coruña(Current)

Institut Català d'Oncologia

Universidade da Coruña

Hospital de Sant Pau

Vall d'Hebron Hospital Universitari

Rosario García Campelo is an author at Complexo Hospitalario Universitario A Coruña specializing in oncology, medicine, and non-small cell lung cancer therapy.

ORCID

Publications per year

2008–2024

Publications

First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study

Jean‐Charles Soria, Daniel S.W. Tan, Rita Chiari et al. · The Lancet · 2017 · 1.2K citations

Medicine, Oncology, Pharmacology +14

Brigatinib versus Crizotinib in <i>ALK</i> -Positive Non–Small-Cell Lung Cancer

D. Ross Camidge, Hye Ryun Kim, Myung‐Ju Ahn et al. · New England Journal of Medicine · 2018 · 976 citations · Full text

Medicine, Oncology, Pharmacology +13

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study

Antonio Passaro, Jing Wang, Yan Wang et al. · Annals of Oncology · 2023 · 396 citations · Full text

Medicine, Oncology, Pharmacology +17

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial

Sanjay Popat, Alessandra Curioni‐Fontecedro, Urania Dafni et al. · Annals of Oncology · 2020 · 273 citations · Full text

Medicine, Oncology, Pharmacology +16

Potential Role of Sugar Transporters in Cancer and Their Relationship with Anticancer Therapy

Angélica Figueroa, Enrique Grande Pulido, Rosario García Campelo et al. · International Journal of Endocrinology · 2010 · 175 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 31